Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
KRKRSAthis companyKorsana Biosciences, Inc.	$31.33	-1.17×	0.45×	1.97×	-0.24×	-78.7%	100.0%	-239.8%	-170.1%	-38.8%	-54.7%	-80.9%	0×	0.92×	0×	5.15×	0.0%	1	-10.47	1	C-
AIMAIM ImmunoTech Inc.	$0.16	-0.13×	-0.19×	20.78×	-0.45×	-2271.9%	-284.1%	-11961.4%	-15861.4%	142.7%	-313.6%	-619.7%	-0.5×	-0.31×	-12.96×	0.53×	0.0%	3	-51.36	2	C
KTTAPasithea Therapeutics Corp.	$0.57	-0.44×	0.16×	0×	2.28×	2031.8%	0.0%	0.0%	0.0%	-37.0%	-37.7%	-167.7%	0×	2.73×	0×	11.35×	0.0%	2	1.38	2	B-
QNRXQuoin Pharmaceuticals, Ltd.	$3.71	-1.36×	1.65×	0×	241.74×	63270.6%	0.0%	0.0%	0.0%	-120.5%	-109.7%	-62.6%	0×	243.12×	0×	3.61×	0.0%	1	-13.64	2	C+
TCRTAlaunos Therapeutics, Inc.	$1.76	-1.47×	2.92×	1,258.64×	-1.18×	-81.2%	-27160.0%	-84500.0%	-83520.0%	-194.0%	-196.2%	-47.1%	0×	0.33×	0×	2.45×	0.0%	1	-860.38	1	C-
Peer median	—	-0.9×	0.91×	10.39×	0.92×	975.3%	-142.0%	-5980.7%	-7930.7%	-78.7%	-153.0%	-115.2%	0×	1.53×	0×	3.03×	0.0%	2	-32.5	2	—